文献速递妇科产科

育龄期雌激素暴露持续时间、月经初潮年龄和绝经年龄与心血管疾病事件、全因及心血管死亡风险:系统综述与荟萃分析

Duration of estrogen exposure during reproductive years, age at menarche and age at menopause, and risk of cardiovascular disease events, all-cause and cardiovascular mortality: a systematic review and meta-analysis.
PubMed 文献 · BJOG · 2020-11-05

该系统综述与荟萃分析检索了截至2020年6月28日的PubMed、Embase和Web of Science文献,共纳入75项观察性研究进行证据综合,其中17项纳入荟萃分析。育龄期长度是雌激素暴露最常用的测量方法;较短的育龄期与心血管疾病事件风险升高相关,卒中事件的合并相对风险(95%CI)为1.31(1.25-1.36)。

要点

  • 育龄期长度是雌激素暴露最常用的测量方法。
  • 较短的育龄期与心血管疾病事件风险升高相关,尤其是卒中。
  • 卒中事件的合并相对风险(95%CI)为1.31(1.25-1.36)。

核心结论

  • 育龄期长度是流行病学研究中雌激素暴露最常用的测量方法。
  • 较短的育龄期与心血管疾病事件风险升高相关,尤其是卒中。

研究设计与样本

  • 系统综述与荟萃分析,检索PubMed、Embase和Web of Science截至2020年6月28日发表的文献。
  • 共75项研究纳入证据综合,其中17项纳入荟萃分析。
  • 纳入观察性研究,涉及雌激素暴露测量及月经初潮年龄和绝经年龄的相互效应与心血管疾病事件风险。
  • 研究未接受外部资助。

主要发现

  • 育龄期长度(绝经年龄减初潮年龄)、内源性雌激素暴露和总雌激素暴露用于雌激素暴露测量。
  • 育龄期长度是迄今最常用的雌激素暴露测量方法。
  • 较短的育龄期与心血管疾病事件风险升高相关;卒中事件的合并相对风险(95%CI)为1.31(1.25-1.36)。

关键数值与推荐

  • 较短的育龄期与卒中事件风险升高相关,合并相对风险(95%CI)为1.31(1.25-1.36)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 需要测量雌激素暴露及相关健康风险的稳健流行病学研究来加强证据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Little is known about the estrogen exposure measurement and mutual effect of age at menarche and age at menopause in the risk of cardiovascular disease (CVD) events. OBJECTIVES: To evaluate estrogen exposure measurement and describe mutual effect of age at menarche and age at menopause in the risk of CVD events. SEARCH STRATEGY: Systematic review of literature in PubMed, Embase and Web of Science for studies published up to 28 June 2020. SELECTION CRITERIA: Observational studies related to estrogen exposure measurement, including mutual effect of age at menarche and age at menopause and risk of CVD events. DATA COLLECTION AND ANALYSIS: Synthesis of evidence was conducted by reviewing individual estimates, followed by meta-analysis. The study received no external funding. MAIN RESULTS: A total of 75 studies were included in synthesis of evidence, of which 17 studies were included in meta-analysis. Reproductive lifespan (age at menopause - age at menarche), endogenous estrogen exposure and total estrogen exposure were used for estrogen exposure measurement. Reproductive lifespan was by far the most commonly used method for estrogen exposure measurement. A shorter reproductive lifespan was associated with a higher risk of CVD events; the pooled relative risk (95% CI) was 1.31 (1.25-1.36) for stroke events. Robust epidemiological studies with measurement of estrogen exposure and associated health risk would strengthen the evidence. CONCLUSIONS: Reproductive lifespan was the most commonly used method for estrogen exposure measurement in epidemiological studies. A shorter reproductive lifespan was associated with a higher risk of CVD events, particularly stroke. TWEETABLE ABSTRACT: A systematic review and meta-analysis found that women with a shorter reproductive lifespan have a higher risk of stroke events.

来源:BJOG,查看原文。版权归原作者所有。

引用

  1. Mishra SR, Chung HF, Waller M, et al. Duration of estrogen exposure during reproductive years, age at menarche and age at menopause, and risk of cardiovascular disease events, all-cause and cardiovascular mortality: a systematic review and meta-analysis. BJOG. 2020. PMID: 32965759. doi:10.1111/1471-0528.16524

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。